Top Story

ASH announces training program participants

ASH announces training program participants
May 24, 2015

ASH and the European Hematology Association released the names of 20 early-career hematologists who are participating in the 2015 Translational Research in Hematology joint program.

The TRTH program, in its sixth year, helps junior scientists build successful careers in hematologic translational research through a rigorous year-long training and mentoring experience. Participants include medical, biomedical and pharmaceutical doctorate trainees actively employed in a hematology-related research environment who are junior faculty or program leaders and have completed their fellowship training within the past 3 years.

Martin McMahon, PhD Institution Notes

Cancer institute appoints senior director

May 23, 2015
Martin McMahon, PhD, has been appointed professor in the department of dermatology and senior director of pre-clinical translation at Huntsman Cancer Institute at the…
In the Journals

Statins may lower mortality risk in patients with lung cancer

May 22, 2015
Statin use in the year before and after diagnosis was linked to decreased mortality risk in patients with lung cancer, according to results of a population-based cohort…
Meeting News Coverage

Spirituality, religiosity increased quality of life among patients with cancer

May 22, 2015
TORONTO — Among patients with cancer, having a high sense of spirituality and/or religiosity increased mental health quality of life, according to data presented…

Keytruda recommended for approval in Europe as advanced melanoma treatment

May 22, 2015
Merck announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion in recommending Keytruda for…
More News Headlines »
CME CNE
Stem Cell Transplant for AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
Meeting News Coverage Video
VIDEO: Updates in prostate cancer treatment options

VIDEO: Updates in prostate cancer treatment options

May 5, 2015
Robert S. DiPaola, MD, director of Rutgers Cancer Institute of New Jersey, discusses various forms of prostate cancer…
More »
CME
New Advances, New Options: Evaluating the Changing Landscape of Hemophilia

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances…
More »